You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨利好疊加 亞盛醫藥-B(6855.HK)大漲超11%
格隆匯 07-21 14:14
格隆匯7月21日丨亞盛醫藥-B(6855.HK)大幅拉昇漲超11%,報53.2港元,成交額達2.32億港元,總市值135億港元。7月亞盛醫藥陸續迎來利好消息。日前公司與美國國家癌症研究所達成合作,雙方將針對公司原創雙靶點Bcl-2/Bcl-xL抑制劑APG-1252(Pelcitoclax)展開臨牀與非臨牀開發方面的合作;另外公司已與信達生物達成2.45億美元戰略合作,涉及HQP1351中國商業推廣、APG-2575聯合臨牀開發、股權投資等多領域;公司亞盛天使基金已正式啟動,該基金將專注生物醫藥產業早期投資。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account